We make the invisible visible
Since 19 November, twelve beamlines at MAX IV are taking light, which is a record number in the history. The former MAX-lab, which closed in 2015, had at the most eleven beamlines up and running. MAX IV has now, with a little over three years going since the first beamline went into operation surpassed this
On Thursday November 14, the team at the CoSAXS beamline detected the first monochromatic light, a crucial step in the beamline commissioning activities. The CoSAXS beamline, set to become an advanced multipurpose Small Angle X-ray Scattering (SAXS) instrument, reached an critical landmark last week when the team detected the first monochromatic light. This detection
image: Researcher Saeed Saedy demonstrates his work with the HIPPIE beamline. The Swedish Institute (SI) offered a scholarship-based training programme at MAX IV in 2019 for researchers from the eight Middle Eastern countries affiliated with SESAME—Synchotron-light for Experimental Science and Applications in the Middle East—light source located in Jordan. During the autumn, two visiting
image: Researcher Neama Imam in the Balder beamline control room. The Swedish Institute (SI) offered a scholarship-based training programme at MAX IV in 2019 for researchers from the eight Middle Eastern countries affiliated with SESAME—Synchotron-light for Experimental Science and Applications in the Middle East—light source located in Jordan. During the autumn, two visiting researchers
image (from left): Balder Beamline Scientist Kajsa Sigfridsson Clauss and Researcher Martin Magnuson adjust settings on the beamline. BALDER beamline—In operation since September, Balder beamline has taken its first users to investigate MXenes, a class of nano-crystalline 2D-layered transition metal carbides, carbonitrides and nitrides. Researchers aim to learn more about their fascinating characteristics and
At October 31, 2019, the BioMAX team performed together with AstraZeneca the first 8-hour remote operation experiment. The researchers from AstraZeneca in Mölndal connected successfully to the BioMAX beamline remotely (left picture) and collected data from many samples during their 8-hour beamtime. Ana Gonzalez from the BioMAX team observed together with Helena Käck from AstraZeneca